Comparative Study of Hydroxychloroquine and Ivermectin in COVID-19 Prophylaxis

Moraes et al., NCT04384458, NCT04384458, Apr 2021

Ivermectin for COVID-19

4th treatment shown to reduce risk in August 2020, now with p < 0.0000000001 from 106 studies, recognized in 24 countries.

No treatment is 100% effective.
Protocols combine treatments.

Estimated 400 participant ivermectin vs. HCQ prophylaxis RCT with results not reported over 5 years after estimated completion.
3 ivermectin RCTs have results missing long after expected1-3
The trials report an estimated total of 912 patients.
Study covers ivermectin and HCQ.
Moraes et al., 30 Apr 2021, Randomized Controlled Trial, this trial compares with another treatment - results may be better when compared to placebo, trial NCT04384458 (history).